nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbinoxamine—CYP2E1—Thalidomide—leprosy	0.112	0.114	CbGbCtD
Carbinoxamine—CYP2E1—Rifampicin—leprosy	0.109	0.111	CbGbCtD
Carbinoxamine—CYP2B6—Rifampicin—leprosy	0.107	0.109	CbGbCtD
Carbinoxamine—CYP2E1—Dapsone—leprosy	0.0896	0.0913	CbGbCtD
Carbinoxamine—CYP2C8—Rifampicin—leprosy	0.0811	0.0826	CbGbCtD
Carbinoxamine—CYP2C19—Thalidomide—leprosy	0.0702	0.0716	CbGbCtD
Carbinoxamine—CYP2C19—Rifampicin—leprosy	0.068	0.0693	CbGbCtD
Carbinoxamine—CYP2C8—Dapsone—leprosy	0.0669	0.0682	CbGbCtD
Carbinoxamine—CYP2C9—Thalidomide—leprosy	0.0584	0.0595	CbGbCtD
Carbinoxamine—CYP2C9—Rifampicin—leprosy	0.0565	0.0576	CbGbCtD
Carbinoxamine—CYP2C19—Dapsone—leprosy	0.0561	0.0572	CbGbCtD
Carbinoxamine—CYP2C9—Dapsone—leprosy	0.0467	0.0476	CbGbCtD
Carbinoxamine—CYP3A4—Rifampicin—leprosy	0.0329	0.0335	CbGbCtD
Carbinoxamine—CYP3A4—Dapsone—leprosy	0.0271	0.0277	CbGbCtD
Carbinoxamine—Neuritis—Thalidomide—leprosy	0.00104	0.0553	CcSEcCtD
Carbinoxamine—Photosensitivity reaction—Dapsone—leprosy	0.000868	0.0462	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Dapsone—leprosy	0.000831	0.0442	CcSEcCtD
Carbinoxamine—Tinnitus—Dapsone—leprosy	0.000709	0.0378	CcSEcCtD
Carbinoxamine—Euphoric mood—Thalidomide—leprosy	0.000666	0.0355	CcSEcCtD
Carbinoxamine—Photosensitivity—Thalidomide—leprosy	0.000641	0.0341	CcSEcCtD
Carbinoxamine—Vision blurred—Dapsone—leprosy	0.000624	0.0332	CcSEcCtD
Carbinoxamine—Vertigo—Dapsone—leprosy	0.000595	0.0317	CcSEcCtD
Carbinoxamine—Diplopia—Thalidomide—leprosy	0.000563	0.03	CcSEcCtD
Carbinoxamine—Tachycardia—Dapsone—leprosy	0.000528	0.0281	CcSEcCtD
Carbinoxamine—Insomnia—Dapsone—leprosy	0.000489	0.026	CcSEcCtD
Carbinoxamine—Pollakiuria—Thalidomide—leprosy	0.00045	0.0239	CcSEcCtD
Carbinoxamine—Photosensitivity reaction—Thalidomide—leprosy	0.000444	0.0236	CcSEcCtD
Carbinoxamine—Drowsiness—Thalidomide—leprosy	0.000434	0.0231	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Thalidomide—leprosy	0.000425	0.0226	CcSEcCtD
Carbinoxamine—Agranulocytosis—Thalidomide—leprosy	0.000405	0.0216	CcSEcCtD
Carbinoxamine—Tinnitus—Thalidomide—leprosy	0.000363	0.0193	CcSEcCtD
Carbinoxamine—Chills—Thalidomide—leprosy	0.00035	0.0186	CcSEcCtD
Carbinoxamine—Vomiting—Dapsone—leprosy	0.000344	0.0183	CcSEcCtD
Carbinoxamine—Headache—Dapsone—leprosy	0.000339	0.018	CcSEcCtD
Carbinoxamine—Tension—Thalidomide—leprosy	0.000333	0.0177	CcSEcCtD
Carbinoxamine—Nervousness—Thalidomide—leprosy	0.000329	0.0175	CcSEcCtD
Carbinoxamine—Nausea—Dapsone—leprosy	0.000321	0.0171	CcSEcCtD
Carbinoxamine—Vision blurred—Thalidomide—leprosy	0.00032	0.017	CcSEcCtD
Carbinoxamine—Tremor—Thalidomide—leprosy	0.000318	0.0169	CcSEcCtD
Carbinoxamine—Agitation—Thalidomide—leprosy	0.000312	0.0166	CcSEcCtD
Carbinoxamine—Vertigo—Thalidomide—leprosy	0.000305	0.0162	CcSEcCtD
Carbinoxamine—Palpitations—Thalidomide—leprosy	0.0003	0.016	CcSEcCtD
Carbinoxamine—Convulsion—Thalidomide—leprosy	0.000294	0.0156	CcSEcCtD
Carbinoxamine—Confusional state—Thalidomide—leprosy	0.000279	0.0149	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Thalidomide—leprosy	0.000271	0.0144	CcSEcCtD
Carbinoxamine—Tachycardia—Thalidomide—leprosy	0.00027	0.0144	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Thalidomide—leprosy	0.000268	0.0142	CcSEcCtD
Carbinoxamine—Anorexia—Thalidomide—leprosy	0.000264	0.014	CcSEcCtD
Carbinoxamine—Hypotension—Thalidomide—leprosy	0.000259	0.0138	CcSEcCtD
Carbinoxamine—Insomnia—Thalidomide—leprosy	0.00025	0.0133	CcSEcCtD
Carbinoxamine—Paraesthesia—Thalidomide—leprosy	0.000249	0.0132	CcSEcCtD
Carbinoxamine—Somnolence—Thalidomide—leprosy	0.000246	0.0131	CcSEcCtD
Carbinoxamine—Dyspepsia—Thalidomide—leprosy	0.000244	0.013	CcSEcCtD
Carbinoxamine—Decreased appetite—Thalidomide—leprosy	0.000241	0.0128	CcSEcCtD
Carbinoxamine—Fatigue—Thalidomide—leprosy	0.000239	0.0127	CcSEcCtD
Carbinoxamine—Constipation—Thalidomide—leprosy	0.000237	0.0126	CcSEcCtD
Carbinoxamine—Feeling abnormal—Thalidomide—leprosy	0.000228	0.0121	CcSEcCtD
Carbinoxamine—Urticaria—Thalidomide—leprosy	0.00022	0.0117	CcSEcCtD
Carbinoxamine—Asthenia—Thalidomide—leprosy	0.000199	0.0106	CcSEcCtD
Carbinoxamine—Diarrhoea—Thalidomide—leprosy	0.000189	0.0101	CcSEcCtD
Carbinoxamine—Dizziness—Thalidomide—leprosy	0.000183	0.00974	CcSEcCtD
Carbinoxamine—Vomiting—Thalidomide—leprosy	0.000176	0.00937	CcSEcCtD
Carbinoxamine—Headache—Thalidomide—leprosy	0.000173	0.00923	CcSEcCtD
Carbinoxamine—Nausea—Thalidomide—leprosy	0.000164	0.00875	CcSEcCtD
